Survival of Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification.

TitleSurvival of Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification.
Publication TypeJournal Article
Year of Publication2002
AuthorsGhigo E, Capo C, Aurouze M, Tung C-H, Gorvel J-P, Raoult D, Mege J-L
JournalInfect Immun
Volume70
Issue3
Pagination1501-6
Date Published2002 Mar
ISSN0019-9567
KeywordsAcids, Actinobacteria, Antigens, CD, Cathepsin D, HeLa Cells, Humans, Hydrogen-Ion Concentration, Lysosome-Associated Membrane Glycoproteins, Lysosomes, Membrane Fusion, Membrane Glycoproteins, Phagosomes, Vacuoles, Whipple Disease
Abstract

Tropheryma whipplei was established as the agent of Whipple's disease in 2000, but the mechanisms by which it survives within host cells are still unknown. We show here that T. whipplei survives within HeLa cells by controlling the biogenesis of its phagosome. Indeed, T. whipplei colocalized with lysosome-associated membrane protein 1, a membrane marker of late endosomal and lysosomal compartments, but not with cathepsin D, a lysosomal hydrolase. This defect in phagosome maturation is specific to live organisms, since heat-killed bacilli colocalized with cathepsin D. In addition, T. whipplei survived within HeLa cells by adapting to acidic pH. The vacuoles containing T. whipplei were acidic (pH 4.7 +/- 0.3) and acquired vacuolar ATPase, responsible for the acidic pH of late phagosomes. The treatment of HeLa cells with pH-neutralizing reagents, such as ammonium chloride, N-ethylmaleimide, bafilomycin A1, and chloroquine, increased the intravacuolar pH and promoted the killing of T. whipplei. The ability of T. whipplei to survive in an acidic environment and to interfere with phagosome-lysosome fusion is likely critical for its prolonged persistence in host cells during the course of Whipple's disease. Our results suggest that manipulating the intravacuolar pH may provide a new approach for the treatment of Whipple's disease.

DOI10.1128/IAI.70.3.1501-1506.2002
Alternate JournalInfect Immun
PubMed ID11854238
PubMed Central IDPMC127739
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065